Testosterone replacement in men with T2DM lowers HbA1c: ABCD worldwide audit

[madman]

At EASD 2023 in Hamburg, Professor Hugh Jones presents an analysis from the ABCD audit of Testosterone in Men with Type 2 Diabetes, confirming that testosterone replacement therapy does improve glycaemic control. Furthermore, the data showed that HbA1c continues to decrease over time. This was likely to be due to the ongoing effect of testosterone on fat reduction.

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

Dr. Jones is ahead of the game!

Take note!

 

[madman]

T therapy may lower HbA1c for men with T2DM and hypogonadism

https://www.healio.com/news/endocrinology/20231004/testosterone-therapy-may-lower-hba1c-for-men-with-type-2-diabetes-hypogonadism Key takeaways: Men with type 2 diabetes and hypogonadism receiving testosterone therapy had reductions in HbA1c at 3 months, 1 year, and 2 years. More data are...

www.excelmale.com

 

[madman]

Testosterone for Diabetes Mellitus (T4DM) Study with Dr. Abe Morgentaler

The T4DM study is the world's largest, randomized, controlled trial of testosterone therapy. The study found that testosterone treatment greatly reduced the number of men who progressed to real diabetes. There was also a percentage of men who started the study with diabetes and by the end of the...

www.excelmale.com